Multiple antigen-specific processing pathways for activating naive CD8+ T cells in vivo

Journal of Immunology

Volumn 166, Issue 7, 2001, Pages 4355-4362

  Norbury, C C ^a   Princiotta, M F ^a   Bacik, I ^a   Brutkiewicz, R R ^a   Wood, P ^a   Elliott, T ^a   Bennink, J R ^a   Yewdell, J W ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CD8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; OVALBUMIN; PROTEIN TAP; UNCLASSIFIED DRUG; VIRUS ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; VACCINIA VIRUS;

EID: 0035313036     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.7.4355     Document Type: Article

References (47)

1. Antigen recognition by class I-restricted T lymphocytes
2. Cell biology of antigen processing and presentation to MHC class I molecule-restricted T lymphocytes
3. Proteolysis, proteasomes and antigen processing
4. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules
5. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes
6. Peptide translocation by variants of the transporter associated with antigen processing
7. Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter
8. Evidence that transporters associated with antigen processing translocate a major histocompatibility complex class I-binding peptide into the endoplasmic reticulum in an ATP-dependent manner
9. Generation and TAP-mediated transport of peptides for major histocompatibility complex class I molecules
10. - T cells
11. Endogenously synthesized peptide with an endoplasmic reticulum signal sequence sensitizes antigen processing mutant cells to class I-restricted cell-mediated lysis
12. HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides
13. HLA-A2.1-associated peptides from a mutant line: A second pathway of antigen presentation
14. TAP-independent presentation of endogenously synthesized peptides is enhanced by endoplasmic reticulum insertion sequences located at the amino but not carboxy terminus of the peptide
15. Antigen processing in vivo and the elicitation of primary CTL responses
16. An endoplasmic reticulum-targeting signal sequence enhances the immunogenicity of an immunorecessive simian virus 40 large T antigen cytotoxic T-lymphocyte epitope
17. Promiscuous liberation of MHC-class I-binding peptides from the C termini of membrane and soluble proteins in the secretory pathway
18. Glycan-regulated antigen processing of a protein in the endoplasmic reticulum can uncover cryptic cytotoxic T cell epitopes
19. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay
20. T cell receptor antagonist peptides induce positive selection
21. Thymic depletion and peripheral activation of class I major histocompatibility complex-restricted T cells by soluble peptide in T-cell receptor transgenic mice
22. Introduction of a glycosylation site into a secreted protein provides evidence for a novel antigen processing pathway: Transport of precursors of MHC class I restricted-peptides from the endoplasmic reticulum to the cytosol
23. Processing of major histocompatibility class I-restricted antigens in the endoplasmic reticulum
24. Assembly, intracellular localization, and nucleotide binding properties of the human peptide transporters Tap1 and Tap2 expressed by recombinant vaccinia viruses
25. Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody
26. Vaccinia virus expression vector: Coexpression of β-galactosidase provides visual screening of recombinant virus plaques
27. Constitutive macropinocytosis allows TAP-dependent major histocompatibility complex class I presentation of exogenous soluble antigen by bone marrow-derived dendritic cells
28. Cell growth and the initiation of transformation by SV40
29. Identification of human cancers deficient in antigen processing
30. Presentation of viral antigen controlled by a gene in the major histocompatibility complex
31. Dissociation of proteasomal degradation of biosynthesized viral proteins from generation of MHC class I-associated antigenic peptides
32. + T cell repertoire that displays both diversity and peptide specificity
33. + T cells in mice with defects in the MHC class I antigen-presenting pathway
34. The effect of mutations in the MHC class I peptide binding groove on the cytotoxic T lymphocyte recognition of the Kb-restricted ovalbumin determinant
35. Gene expression and cytopathic effect of vaccinia virus inactivated by psoralen and long-wave UV light
36. Major histocompatibility class I presentation of ovalbumin peptide 257-264 from exogenous sources: Protein context influences the degree of TAP-independent presentation
37. TAP-translocated peptides specifically bind proteins in the endoplasmic reticulum, including gp96, protein disulfide isomerase and calreticulin
38. The endoplasmic reticulum-resident stress protein gp96 binds peptides translocated by TAP
39. Protein disulfide isomerase is the dominant acceptor for peptides translocated into the endoplasmic reticulum
40. Cellular peptide composition governed by major histocompatibility complex class I molecules
41. Receptor-mediated uptake of antigen/heat shock protein complexes results in major histocompatibility complex class I antigen presentation via two distinct processing pathways
42. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen
43. Temporal regulation of influenza hemagglutinin expression in vaccinia virus recombinants and effects on the immune response
44. Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine
45. A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides
46. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
47. Immunogenicity of apoptotic cells in vivo: Role of antigen load, antigen-presenting cells, and cytokines